Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
| Website | https://www.theolytics.com |
| Employees | 30 (22 on RocketReach) |
| Founded | 2017 |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Medical, Health Care, Therapeutics |
| Keywords | Oncolytic Virus, Platform Technology, Viral Therapy, Oncology, Cancer Treatment, Cancer Research, Cancer Immunotherapy, Immuno-Oncology, Molecular Medicine, Biotechnology, Biopharma, Gene Therapy, Drug Discovery, Pharmaceutical, New Drug Development, Targeted Therapy, Clinical Trials |
| Competitors | Bristol Myers Squibb, AstraZeneca, Novartis, Regeneron, CureVac, Moderna Therapeutics, Zymeworks Inc., Immatics, Genmab, Lilly India +37 more (view full list) |
Looking for a particular Theolytics employee's phone or email?
Margaret Duffy is the Co-Founder and Chief Scientific Officer of Theolytics.
22 people are employed at Theolytics.
Theolytics is based in Oxford, England.